Resolvin D1 protects against sepsis‐induced cardiac injury in mice
Authors:
- 15 July 2020
- journal article
- research article
- Published by Wiley in BioFactors
- Vol. 46 (5) , 766-776
Abstract
Increased inflammation is the key mechanism that mediates sepsis induced cardiac injury. Resolvin D1 (RvD1), a bioactive lipid mediator synthesized from docosahexaenoic acid, can attenuate the severity of many inflammation‐related diseases through anti‐inflammatory and pro‐resolving properties. However, the protective role of RvD1 in sepsis induced cardiac injury remains unclear. Mice were randomly divided into three groups: the control group, LPS group and RvD1 + LPS group. LPS (10 mg/kg, i.p.) was used to establish a sepsis‐induced cardiac injury model. RvD1 (5 ug/kg, i.p.) was injected 30 min before LPS injection. RvD1 treatment significantly attenuated the deteriorated cardiac function and cardiac injury induced by LPS, as evidenced by the improved left ventricular ejection fraction, serum levels of cardiac injury markers and severity of cardiomyocyte apoptosis. In addition, RvD1 treatment significantly attenuated the infiltration of pro‐inflammatory M1 macrophages and expression of inflammatory cytokines in the heart. Mechanistically, the attenuated activation of NK‐κB and MAPK signaling mediated the anti‐inflammatory and antiapoptotic effects of RvD1. In addition, LPS‐induced infiltration of neutrophils and M1 macrophages in the spleen was significantly attenuated by the RvD1 treatment. Results of the present study suggest that RvD1 protects the heart against LPS‐induced injuries by attenuating the local and systemic inflammatory response, highlighting the therapeutic effects of RvD1 in sepsis‐induced cardiac injury.Keywords
Funding Information
- Fundamental Research Funds for the Central Universities of China (2042019kf0065)
This publication has 43 references indexed in Scilit:
- Resolvin D1-mediated NOX2 inactivation rescues macrophages undertaking efferocytosis from oxidative stress-induced apoptosisBiochemical Pharmacology, 2013
- Resolvin D1, an Endogenous Lipid Mediator for Inactivation of Inflammation‐Related Signaling Pathways in Microglial Cells, Prevents Lipopolysaccharide‐Induced Inflammatory ResponsesCNS Neuroscience & Therapeutics, 2013
- The role of the Hsp90/Akt pathway in myocardial calpain-induced caspase-3 activation and apoptosis during sepsisBMC Cardiovascular Disorders, 2013
- Resolvin D1 and Resolvin E1 Promote the Resolution of Allergic Airway Inflammation via Shared and Distinct Molecular Counter-Regulatory PathwaysFrontiers in Immunology, 2012
- Mitogen-activated protein kinase phosphatase-1 inhibits myocardial TNF- expression and improves cardiac function during endotoxemiaCardiovascular Research, 2011
- Endogenous anti‐inflammatory neuropeptides and pro‐resolving lipid mediators: a new therapeutic approach for immune disordersJournal of Cellular and Molecular Medicine, 2008
- Harmful molecular mechanisms in sepsisNature Reviews Immunology, 2008
- Actual incidence of global left ventricular hypokinesia in adult septic shockCritical Care Medicine, 2008
- Mechanisms of sepsis-induced cardiac dysfunctionCritical Care Medicine, 2007
- Early Goal-Directed Therapy in the Treatment of Severe Sepsis and Septic ShockNew England Journal of Medicine, 2001